dc.contributor.author |
Appiah–Thompson, Peter |
|
dc.contributor.author |
Awuku, Yaw Asante |
|
dc.contributor.author |
Masiowski, Paul |
|
dc.contributor.author |
Appiah–Thompson, Benedicta L. |
|
dc.contributor.author |
Dampson, Olukemi Olawaiye |
|
dc.date.accessioned |
2023-10-23T16:02:05Z |
|
dc.date.available |
2023-10-23T16:02:05Z |
|
dc.date.issued |
2015 |
|
dc.identifier.issn |
2231-0614 |
|
dc.identifier.uri |
http://hdl.handle.net/123456789/9890 |
|
dc.description.abstract |
Myasthenia gravis (MG) is a chronic neuromuscular junction (NMJ) dysfunction with a wide spectrum of neurological manifestations. MG is as a result of autoantibodies directed against NMJ at the postsynaptic level involving nicotinic or other postsynaptic antigens. The newly identified subtype of MG with antibodies against the muscle-specific receptor tyrosine kinase (Anti-MuSK) shows an unpredictable response to current MG treatment. The initial presentation of this disease entity often poses a diagnostic challenge and a treatment dilemma to the clinician. We present a case of life-threatening Anti-MuSK-positive myasthenic crisis occurring during puerperium which required a temporary surgical airway and percutaneous endoscopic gastrostomy tube for feeding. She had dysphonia for 7 years but was not diagnosed. The complications and management dilemma of this case report are highlighted. |
en_US |
dc.language.iso |
en |
en_US |
dc.publisher |
British Journal of Medicine & Medical Research |
en_US |
dc.subject |
Myasthenia gravis |
en_US |
dc.subject |
Myasthenic crisis |
en_US |
dc.subject |
Anti-MuSK |
en_US |
dc.subject |
Puerperium |
en_US |
dc.title |
Anti-musk Myasthenic Crisis in the Puerperium: The Management Dilemma |
en_US |
dc.type |
Article |
en_US |